FdaApplication
ANDA 216932
Identifiers
- fda_app_no: ANDA216932
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2022-10-12 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ALYQ | TADALAFIL | 20MG | TABLET;ORAL |
1 product